Doximity, Inc. income statement
In fiscal 2026, Doximity, Inc. reported revenue of $645m, up 13.1% on the year before, operating income of $215m (a 33.3% margin) and net income of $196m, or $0.98 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.
Income statement
| Fiscal year | 2020Mar 2020 | 2021Mar 2021 | 2022Mar 2022 | 2023Mar 2023 | 2024Mar 2024 | 2025Mar 2025 | 2026Mar 2026 | LTMJun 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 116 | 207 | 344 | 419 | 475 | 570 | 645 | 656 |
| Cost of revenue | 15 | 31 | 40 | 53 | 51 | 56 | 70 | 78 |
| Gross profit | 101 | 176 | 304 | 366 | 425 | 515 | 575 | 577 |
| Research and development | 32 | 44 | 62 | 80 | 82 | 93 | 131 | 142 |
| Selling and marketing | 39 | 62 | 92 | 124 | 133 | 146 | 164 | 172 |
| General and administrative | 7 | 16 | 36 | 37 | 38 | 46 | 65 | 69 |
| Operating income | 22 | 53 | 114 | 125 | 164 | 228 | 215 | 194 |
| Income before tax | 24 | 58 | 114 | 133 | 185 | 264 | 250 | 226 |
| Income tax | −6 | 8 | −41 | 20 | 38 | 40 | 54 | 59 |
| Net income | 30 | 50 | 155 | 113 | 148 | 223 | 196 | 167 |
| Diluted EPS | $0.07 | $0.12 | $0.70 | $0.53 | $0.72 | $1.11 | $0.98 | $0.85 |
| Diluted shares (average) | 163m | 190m | 191m | 213m | 206m | 201m | 199m | 197m |
| EBITDA | 23 | 57 | 119 | 135 | 174 | 238 | 229 | 206 |
| Quarter | 2025 Q2Sept 2024 | 2025 Q3Dec 2024 | 2025 Q4Mar 2025 | 2026 Q1Jun 2025 | 2026 Q2Sept 2025 | 2026 Q3Dec 2025 | 2026 Q4Mar 2026 | 2027 Q1Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 137 | 169 | 138 | 146 | 169 | 185 | 145 | 157 |
| Cost of revenue | 14 | 14 | 14 | 16 | 16 | 19 | 19 | 24 |
| Gross profit | 123 | 154 | 124 | 130 | 152 | 166 | 126 | 133 |
| Research and development | 23 | 22 | 25 | 27 | 30 | 35 | 39 | 38 |
| Selling and marketing | 34 | 38 | 38 | 36 | 39 | 42 | 46 | 45 |
| General and administrative | 10 | 14 | 13 | 12 | 19 | 18 | 16 | 16 |
| Operating income | 53 | 80 | 49 | 55 | 64 | 72 | 25 | 34 |
| Income before tax | 62 | 90 | 58 | 64 | 73 | 81 | 32 | 40 |
| Income tax | 18 | 15 | −4 | 11 | 11 | 19 | 13 | 16 |
| Net income | 44 | 75 | 62 | 53 | 62 | 62 | 19 | 24 |
| Diluted EPS | $0.22 | $0.37 | $0.31 | $0.27 | $0.31 | $0.31 | $0.10 | $0.13 |
| EBITDA | 55 | 81 | 52 | 57 | 66 | 74 | 29 | 38 |
Compare with peers
- Goodrx Holdings, Inc. income statement
- Phreesia, Inc. income statement
- Genedx Holdings Corp. income statement
- Omnicell, Inc. income statement
- Waystar Holding Corp. income statement
Head to head: DOCS vs GDRXDOCS vs PHRDOCS vs WGS
More: Health Care Technology stocks compared, Health Care sector, rankings of US companies